Clinical Evaluation of Ropinirole CR-RLS Tablets in Restless Legs Syndrome-Open-Label, Uncontrolled Study. Classification: Clinical Pharmacology, Exploratory
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2016
At a glance
- Drugs Ropinirole (Primary)
- Indications Restless legs syndrome
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 21 Aug 2009 Planned number of patients changed from 30 to 35 as reported by ClinicalTrials.gov.
- 15 Oct 2008 Actual start date changed from Jul 2007 to Aug 2007 as reported by ClinicalTrials.gov.
- 03 Apr 2008 The expected completion date for this trial is now 1 Feb 2008, reported by ClinicalTrials.gov.